Hygeia Healthcare Holdings Co., Ltd.

Hygeia Healthcare Holdings Co., Ltd.

HHKEX:6078
10.66
HKD
-0.06
(-0.56%)
5.57BMarket Cap
Mar 31Next Earn
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.99
1.28
1.81
3.14
3.75
5.18
6.46
7.07
6.48
- -
Basic EPS, GAAP
-0.08
- -
0.07
0.38
0.71
0.77
1.08
0.95
0.27
- -
Free Cash Flow per Basic Share
-0.27
-0.22
0.11
-0.07
-0.39
0.13
-0.25
0.15
0.75
- -
Dividend per Share
- -
0.03
- -
0.16
0.12
- -
0.15
- -
- -
- -
Book Value per Share
-0.51
-0.32
-0.34
6.91
7.21
8
9.87
10.72
10.97
11.42
Tangible Book Value per Share
-1.16
-0.96
-0.98
6.29
3.36
4.13
3.62
4.37
5.05
5.42
Basic Weighted Avg Shares
600
600
600
447
618
617
631
629
618
616
Sales/Revenue/Turnover
596
766
1,086
1,402
2,315
3,196
4,077
4,446
4,009
- -
Operating Margin (%)
6.85
14.17
16.88
22.96
22.63
22.75
21.44
19.96
15.56
- -
Depreciation Expense
42
49
71
78
114
153
211
295
304
- -
Net Income, GAAP
-46
3
40
170
441
477
683
598
165
- -
Effective Tax Rate (%)
- -
91.13
49.87
29.91
20.89
25.09
19.99
20.31
50.68
- -
Profit Margin (%)
-7.78
0.34
3.66
12.13
19.07
14.92
16.75
13.46
4.1
- -
Working Capital
169
98
-1,046
2,641
866
723
31
30
19
-204
LT Debt
63
45
1
1
1,197
1,106
2,321
2,256
2,002
1,711
Total Equity
-303
-188
-203
4,341
4,478
4,940
6,255
6,674
6,785
6,956
Return on Invested Capital (%)
- -
- -
- -
9.98
9.25
8.25
9.22
7.02
2.06
- -
Return on Capital (%)
- -
-5.4
-52.79
9.5
8.91
8.34
9.41
7.11
2.16
- -
Return on Common Equity (%)
- -
- -
- -
- -
10.12
10.15
12.23
9.29
2.45
- -

Capital Structure

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
624
444
554
LT Borrowings
2,017
1,996
1,706
LT Finance Leases
8
6
5
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
618
617
608
Market Capitalization
8,613
6,886
4,822

Working Capital

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
1,747
1,703
1,544
Cash, Cash Equivalents & STI
672
695
722
Accounts Receivable, Net
735
687
549
Inventories
178
151
122
Total Current Liabilities
1,816
1,684
1,748
Payables & Accruals
- -
- -
- -
ST Debt
624
444
554
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
9.69%
1.65%
Free Cash Flow
- -
110.2%
406.85%
Net Income, GAAP
- -
25.18%
-72.5%
Sales/Revenue/Turnover
- -
26%
-9.84%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
4,446
2025
- -
- -
4,009
2026
- -
- -
- -

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.95
2025
- -
- -
0.27
2026
- -
- -
- -

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Yiwen Zhu
Full Time Employees
7,906
Sector
Health technology
Industry
Pharmaceuticals: major
Address
Unit 1605/1606 Shanghai SH China
IPO Date
Jun 29, 2020
Business
Hygeia Healthcare Holdings Co., Limited (6078.HK) is China's largest oncology-focused healthcare group, owning and operating private for-profit hospitals that provide comprehensive oncology services including radiotherapy, chemotherapy, surgery, targeted therapy, cancer diagnosis, treatment, and rehabilitation; it also offers radiotherapy services to third-party hospitals through consulting, equipment licensing, maintenance, and technical support, alongside hospital management services for private not-for-profit facilities, supply chain operations, and sales of pharmaceuticals, medical consumables, equipment, and proprietary SRT radiotherapy equipment. Founded in 2009 and headquartered in Shanghai, the company primarily serves oncology patients across the People's Republic of China, concentrating operations in the domestic market with a network spanning regions like the Yangtze River Delta and beyond, supported by approximately 8,169 employees. Recent expansions include the openings of Heze Hygeia Hospital and Chongqing Hygeia Hospital in 2024, acquisitions such as a 70% stake in Chang'an Hospital and Datang International (Hong Kong) Limited for CNY 1.2 billion each, an 89.2% stake in Yixing Hygeia Hospital in 2023, and ongoing developments like Wuxi Hygeia Hospital, Changshu Hygeia Hospital, and expansions at Suzhou Yongding Hospital and Qufu Hospital, aiming to grow total hospital beds toward 12,000 by late 2024.